GR-T524-S617

N/A

Report date: 2025/01/26 18:42:41

Base Information

Drug NameGR-T524-S617
Drug Alias NameDimeric peptide (Astrazeneca)GR-T524-S617
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/Indications +[1N/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySweden
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAstrazeneca Plc
China Registration ClassN/A

Develop Information

Active CompaniesAstrazeneca Plc
Inactive CompaniesN/A
Active Indications +[1N/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A